TARIFFS LATEST US, China to slash tariffs for 90 days NYSE - Nasdaq Real Time Price • USD Pediatrix Medical Group, Inc. (MD) Follow Add holdings Time to buy MD? 14.37 -0.16 (-1.10%) As of 3:35:29 PM EDT. Market Open. Time to buy MD? All News Press Releases SEC Filings Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Pediatrix Medical Group Inc (MD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... Pediatrix Medical Group Inc (MD) reports over 6% same unit revenue growth and raises full-year EBITDA outlook, despite a 7% decline in consolidated revenue. Pediatrix Medical Group (NYSE:MD) Posts Better-Than-Expected Sales In Q1 But Stock Drops Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 7.4% year on year to $458.4 million. Its non-GAAP profit of $0.33 per share was 36.7% above analysts’ consensus estimates. Pediatrix Medical Group Reports First Quarter Results FORT LAUDERDALE, Fla., May 06, 2025--Pediatrix Medical Group Reports First Quarter Results Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025 FORT LAUDERDALE, Fla., April 21, 2025--Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025 Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD) If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen. Pediatrix Medical Group's (NYSE:MD) investors will be pleased with their favorable 59% return over the last year The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking... Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen. Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. Wall Street Analysts Believe Pediatrix Medical Group (MD) Could Rally 25.5%: Here's is How to Trade The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Pediatrix Medical Group (MD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Pediatrix Medical Group Full Year 2024 Earnings: EPS Beats Expectations Pediatrix Medical Group ( NYSE:MD ) Full Year 2024 Results Key Financial Results Revenue: US$2.01b (flat on FY 2023... Pediatrix Medical Group Inc (MD) Q4 2024 Earnings Call Highlights: Strong EBITDA and Strategic ... Pediatrix Medical Group Inc (MD) reports robust financial performance with significant EBITDA growth and strategic restructuring, setting a promising tone for 2025. Pediatrix Medical Group’s (NYSE:MD) Q4: Strong Sales Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 1.2% year on year to $502.4 million. Its non-GAAP profit of $0.51 per share was 39.9% above analysts’ consensus estimates. Pediatrix Medical Group Reports Fourth Quarter Results FORT LAUDERDALE, Fla., February 20, 2025--Pediatrix Medical Group Reports Fourth Quarter Results Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21 FORT LAUDERDALE, Fla., February 11, 2025--NEO: The Conference for Neonatology is a premier educational event dedicated to advancing the field of neonatology. Performance Overview Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return MD S&P 500 (^GSPC) YTD +9.53% -0.84% 1-Year +74.82% +11.67% 3-Year -18.77% +48.40%